ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients
- 1 May 2005
- journal article
- guideline
- Published by Elsevier in Annals of Oncology
- Vol. 16 (suppl_1) , i48-i49
- https://doi.org/10.1093/annonc/mdi802
Abstract
1Invited author, Institute of Medical Oncology, Inselspital and University of Berne, CH-3010 Berne, Switzerland; 2Assigned task force member, University Hospital Salzburg, Dept of Hematology/Oncology, Muellnerhauptstrasse 48, 5020 Salzburg, Austria; 3Assigned task force member, Oncology, Kantonsspital, CH-4101 Bruderholz/BL, SwitzerlandKeywords
This publication has 8 references indexed in Scilit:
- Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA groupBlood, 2003
- Combined Treatment With Arsenic Trioxide and All-Trans-Retinoic Acid in Patients With Relapsed Acute Promyelocytic LeukemiaJournal of Clinical Oncology, 2003
- Acute promyelocytic leukemia: evolving therapeutic strategiesBlood, 2002
- Management of Acute Myeloid Leukemia in Elderly PatientsJournal of Clinical Oncology, 1999
- Therapy of Molecular Relapse in Acute Promyelocytic LeukemiaBlood, 1999
- The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 TrialBlood, 1998
- Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous LeukemiaNew England Journal of Medicine, 1995
- Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.Journal of Clinical Oncology, 1990